Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Ena Wang"'
Autor:
Anup Singh, Hari Hariharan, Francesco M. Marincola, Ravinder Reddy, Ena Wang, Mohammad Haris, Arshi Rizwan, Santosh K. Yadav
Publikováno v:
Journal of Translational Medicine
The ability to identify key biomolecules and molecular changes associated with cancer malignancy and the capacity to monitor the therapeutic outcome against these targets is critically important for cancer treatment. Recent developments in molecular
Publikováno v:
Journal of Translational Medicine
Background Dendritic cells (DC) are currently implemented as immunotherapeutic strategy for the treatment of tumor patients based on their central role in the immune system. Despite good results were obtained in vitro and in animal models, their clin
Autor:
Rakesh Gupta, Ena Wang, Santosh K. Yadav, Murali Rangan, Sergio Rutella, Francesco M. Marincola, Mohammad Haris, Silvio Danese, Vivek A. Saraswat, Michael A. Thomas
Publikováno v:
Journal of translational medicine, vol 13, iss 1
Journal of Translational Medicine
Yadav, SK; Gupta, RK; Saraswat, VA; Rangan, M; Thomas, MA; Rutella, S; et al.(2015). Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology. Journal of Translational Medicine, 13(1). doi: 10.1186/s12967-015-0679-6. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4fn1p4fz
Journal of Translational Medicine
Yadav, SK; Gupta, RK; Saraswat, VA; Rangan, M; Thomas, MA; Rutella, S; et al.(2015). Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology. Journal of Translational Medicine, 13(1). doi: 10.1186/s12967-015-0679-6. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4fn1p4fz
Background:\ud \ud Acute-on-chronic liver failure (ACLF) is a form of liver disease with high short-term mortality. ACLF offers considerable potential to affect the cortical areas by significant tissue injury due to loss of neurons and other supporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ef4a4895e3e961757f668c163ef028
Autor:
David S. Stroncek, Paolo A. Ascierto, Michele Sommariva, Muna Al Hashmi, Francesco M. Marincola, Andrea Worschech, Sara Civini, Lotfi Chouchane, Jennifer Reinboth, Lorenzo Uccellini, Ben D. Ayotte, Qiuzhen Liu, Valeria De Giorgi, Sara Tomei, Davide Bedognetti, Giuseppe Palmieri, Maria Libera Ascierto, Ena Wang
Publikováno v:
Molecular oncology
(2014). doi:10.1016/j.molonc.2014.07.014
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1016%2Fj.molonc.2014.07.014/rivista:Molecular oncology (Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Molecular Oncology
Journal of translational medicine (Online) (2015): 1–2. doi:10.1186/1479-5876-13-S1-K19
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1186%2F1479-5876-13-S1-K19/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:1/pagina_a:2/intervallo_pagine:1–2/volume
(2014). doi:10.1016/j.molonc.2014.07.014
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1016%2Fj.molonc.2014.07.014/rivista:Molecular oncology (Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Molecular Oncology
Journal of translational medicine (Online) (2015): 1–2. doi:10.1186/1479-5876-13-S1-K19
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1186%2F1479-5876-13-S1-K19/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:1/pagina_a:2/intervallo_pagine:1–2/volume
Background The existence of a dichotomy between immunologically active and quiescent tumor phenotypes has been recently recognized in several types of cancer. The activation of a Th1 type of immune signature has been shown to confer better prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395923e4fb28c211808315282e37d85b
http://www.cnr.it/prodotto/i/289545
http://www.cnr.it/prodotto/i/289545
Autor:
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, Carlo Bifulco, Alistair Cochran, Claus Garbe, Alexander M Eggermont, Mark Faries, Soldano Ferrone, Jeffrey E Gershenwald, Thomas F Gajewski, Ruth Halaban, F Stephen Hodi, Richard Kefford, John M Kirkwood, James Larkin, Sancy Leachman, Michele Maio, Richard Marais, Giuseppe Masucci, Ignacio Melero, Giuseppe Palmieri, Igor Puzanov, Antoni Ribas, Yvonne Saenger, Bastian Schilling, Barbara Seliger, David Stroncek, Ryan Sullivan, Alessandro Testori, Ena Wang, Gennaro Ciliberto, Nicola Mozzillo, Francesco M Marincola, Magdalena Thurin
Publikováno v:
Journal of translational medicine (Online) (2014). doi:10.1186/s12967-014-0277-z
info:cnr-pdr/source/autori:Ascierto PA, Grimaldi AM, Anderson A, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi F, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M./titolo:Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013./doi:10.1186%2Fs12967-014-0277-z/rivista:Journal of translational medicine (Online)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of translational medicine, vol 12, iss 1
Journal of Translational Medicine
info:cnr-pdr/source/autori:Ascierto PA, Grimaldi AM, Anderson A, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi F, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M./titolo:Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013./doi:10.1186%2Fs12967-014-0277-z/rivista:Journal of translational medicine (Online)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of translational medicine, vol 12, iss 1
Journal of Translational Medicine
The fourth “Melanoma Bridge Meeting” took place in Naples, December 5 to 8th, 2013. The four topics discussed at this meeting were: Diagnosis and New Procedures, Molecular Advances and Combination Therapies, News in Immunotherapy, and Tumor Micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5975d3675a9039e20bd5a5d9842eec6
http://hdl.handle.net/11365/1136637
http://hdl.handle.net/11365/1136637
Autor:
Ena Wang
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A44 (2012)
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A44 (2012)
A cancer immune signature implicating good prognosis and responsiveness to immunotherapy was described that is observed also in other aspects of immune-mediated, tissue-specific destruction (TSD). Its determinism remains, however, elusive. On one sid
Autor:
Kavita Mathi, Diane M. Longo, Brent Louie, Francesco M. Marincola, Zoltan Pos, Alessandra Cesano, Ena Wang, Rachael E. Hawtin
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 113 (2012)
Journal of Translational Medicine
Journal of Translational Medicine
Background Single-cell network profiling (SCNP) is a multi-parametric flow cytometry-based approach that simultaneously measures basal and modulated intracellular signaling activity in multiple cell subpopulations. Previously, SCNP analysis of a broa
Autor:
Marianna Sabatino, Luciano Castiello, Carol Clayberger, Alan M. Krensky, Ena Wang, David F. Stroncek, Michael W. Finn, Francesco M. Marincola
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 41 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 41 (2011)
Background Granulysin is an antimicrobial and proinflammatory protein with several isoforms. While the 9 kDa isoform is a well described cytolytic molecule with pro-inflammatory activity, the functions of the 15 kDa isoform is less well understood. R
Autor:
Masoud H. Manjili, Madhu Gowda, Andrea Worschech, Francesco M. Marincola, Ena Wang, Kamar Godder, Maria-Libera Ascierto, Maciej Kmieciak
Publikováno v:
Journal of Translational Medicine, Vol 9, Iss 1, p 170 (2011)
Journal of Translational Medicine
Journal of Translational Medicine
Background Over 90% of low risk (LR) neuroblastoma patients survive whereas less than 30% of high risk (HR) patients are long term survivors. Age (children younger than 18 months old) is associated with LR disease. Considering that adaptive immune sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb08b13b205b562e7d455b2d0bd83fe
https://doi.org/10.1186/1479-5876-9-170
https://doi.org/10.1186/1479-5876-9-170
Autor:
Andrea Nicolini, Francesco M. Marincola, William E. Carson, Paolo A. Ascierto, Michele Maio, Jedd D. Wolchok, Michael T. Lotze, Jirina Bartunkova, Weihua Xiao, Hauke Winter, Barbara Seliger, Jon M. Wigginton, Cedrik M. Britten, Ignacio Melero, Guido Kroemer, Neil L. Berinstein, Jill O'Donnell-Tormey, Heinz Zwierzina, Lothar Bergmann, Lloyd J. Old, Christian H. Ottensmeier, Jérôme Galon, Per thor Straten, Koji Kawakami, Michael Papamichail, Yutaka Kawakami, Michael I. Nishimura, Mary L. Disis, Steinar Aamdal, C. J. M. Melief, Pedro Romero, Kristen Hege, Wenru Song, Pawel Kalinski, Jonathan L. Bramson, Harpreet Singh-Jasuja, Jens Peter Marschner, Bernard A. Fox, Samir N. Khleif, Brad H. Nelson, Marij J. P. Welters, Elizabeth M. Jaffee, Patrick Hwu, Rik J. Scheper, Robert C. Rees, Giuseppe Masucci, Hideaki Tahara, Cristina Bonorino, Glenn Dranoff, Ernest C. Borden, William J. Murphy, Zhigang Tian, Michael B. Atkins, Robert O. Dillman, Thomas F. Gajewski, Hiroshi Shiku, Leif Håkansson, Michael J. Mastrangelo, Lisa H. Butterfield, Shukui Qin, Laurence Zitvogel, Harry Dolstra, Michele Guida, George Coukos, Mohamed L. Salem, Xuetao Cao, Giorgio Parmiani, Enrico Proietti, Ena Wang, Sylvia Janetzki, A. Raja Choudhury, Gerd Ritter, Hyam I. Levitsky, Kunle Odunsi, Kohzoh Imai, Paul von Hoegen, Christoph Huber, Réjean Lapointe, Antoni Ribas, Dolores J. Schendel, Pamela S. Ohashi, Beatrix Kotlan, Cécile Gouttefangeas, James H. Finke, Alfred E. Chang, Howard L. Kaufman, Lindy G. Durrant, Sjoerd H. van der Burg, Jared Gollob, Dainius Characiejus, Tara Withington, Padmanee Sharma, Ronald B. Herberman, Cristina Maccalli, Ulrich Keilholtz, Axel Hoos, Graham Pawelec, Fabio Grizzi, Tanja D. de Gruijl, F. Stephen Hodi, Ruggero Ridolfi, James P. Allison, Licia Rivoltini, Carl H. June, Rolf Kiessling
Publikováno v:
Journal of Translational Medicine, Vol 9, Iss 1, p 214 (2011)
Journal of Translational Medicine, vol. 9, no. 1, pp. 214
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2011, 9 (1), pp.214. ⟨10.1186/1479-5876-9-214⟩
Journal of Translational Medicine, 2011, 9 (1), pp.214. ⟨10.1186/1479-5876-9-214⟩
Journal of Translational Medicine, 9(1):214. BioMed Central
Fox, BA, Schendel, D J, Butterfield, L H, Aamdal, S, Allison, J P, Ascierto, P A, Atkins, M B, Bartunkova, J, Bergmann, L, Berinstein, N, Bonorino, C C, Borden, E, Bramson, J L, Britten, C M, Cao, X, Carson, W E, Chang, A E, Characiejus, D, Choudhury, A R, Coukos, G, de Gruijl, T D, Dillman, R O, Dolstra, H, Dranoff, G, Durrant, L G, Finke, J H, Galon, J, Gollob, J A, Gouttefangeas, C, Grizzi, F, Guida, M, Hakansson, L, Hege, K, Herberman, R B, Hodi, F S, Hoos, A, Huber, C, Hwu, P, Imai, K, Jaffee, E M, Janetzki, S, June, C H, Kalinski, P, Kaufmann, H L, Kawakami, K, Kawakami, Y, Keilholtz, U, Khleif, S N, Kiessling, R, Kotlan, B, Kroemer, G, Lapointe, R, Levitsky, H I, Lotze, M T, Di Maio, M, Marschner, J P, Mastrangelo, M J, Masucci, G, Melero, I, Nelief, C, Murphy, W J, Nelson, B, Nicolini, A, Nishimura, M I, Odunsi, K, Ohashi, P S, O'Donnell-Tormey, J, Old, L J, Ottensmeier, C, Papamichail, M, Parmiani, G, Pawelec, G, Proietti, E, Qin, S, Rees, R, Ribas, A, Ridolfi, R, Ritter, G, Rivoltini, L, Romero, P J, Salem, M L, Scheper, R J, Seliger, B, Sharma, P, Shiku, H, Singh-Jasuja, H, Song, W, Straten, P T, Tahara, H, Tian, Z, van der Burg, S H, von Hoegen, P, Wang, E, Welters, M J, Winter, H, Withington, T, Wolchok, J D, Xiao, W, Zitvogel, L, Zwierzina, H, Marincola, F M, Gajewski, T F, Wigginton, J M & Disis, M L A 2011, ' Defining the Critical Hurdles in Cancer Immunotherapy ', Journal of Translational Medicine, vol. 9, no. 1, 214 . https://doi.org/10.1186/1479-5876-9-214
Fox, Bernard A; Schendel, Dolores J; Butterfield, Lisa H; Aamdal, Steinar; Allison, James P; Ascierto, Paolo; et al.(2011). Defining the Critical Hurdles in Cancer Immunotherapy. Journal of Translational Medicine, 9(1), 214. doi: http://dx.doi.org/10.1186/1479-5876-9-214. Retrieved from: http://www.escholarship.org/uc/item/34d0r2jw
Journal of Translational Medicine, BioMed Central, 2011, 9 (1), pp.214. 〈10.1186/1479-5876-9-214〉
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Journal of Translational Medicine, vol. 9, no. 1, pp. 214
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2011, 9 (1), pp.214. ⟨10.1186/1479-5876-9-214⟩
Journal of Translational Medicine, 2011, 9 (1), pp.214. ⟨10.1186/1479-5876-9-214⟩
Journal of Translational Medicine, 9(1):214. BioMed Central
Fox, BA, Schendel, D J, Butterfield, L H, Aamdal, S, Allison, J P, Ascierto, P A, Atkins, M B, Bartunkova, J, Bergmann, L, Berinstein, N, Bonorino, C C, Borden, E, Bramson, J L, Britten, C M, Cao, X, Carson, W E, Chang, A E, Characiejus, D, Choudhury, A R, Coukos, G, de Gruijl, T D, Dillman, R O, Dolstra, H, Dranoff, G, Durrant, L G, Finke, J H, Galon, J, Gollob, J A, Gouttefangeas, C, Grizzi, F, Guida, M, Hakansson, L, Hege, K, Herberman, R B, Hodi, F S, Hoos, A, Huber, C, Hwu, P, Imai, K, Jaffee, E M, Janetzki, S, June, C H, Kalinski, P, Kaufmann, H L, Kawakami, K, Kawakami, Y, Keilholtz, U, Khleif, S N, Kiessling, R, Kotlan, B, Kroemer, G, Lapointe, R, Levitsky, H I, Lotze, M T, Di Maio, M, Marschner, J P, Mastrangelo, M J, Masucci, G, Melero, I, Nelief, C, Murphy, W J, Nelson, B, Nicolini, A, Nishimura, M I, Odunsi, K, Ohashi, P S, O'Donnell-Tormey, J, Old, L J, Ottensmeier, C, Papamichail, M, Parmiani, G, Pawelec, G, Proietti, E, Qin, S, Rees, R, Ribas, A, Ridolfi, R, Ritter, G, Rivoltini, L, Romero, P J, Salem, M L, Scheper, R J, Seliger, B, Sharma, P, Shiku, H, Singh-Jasuja, H, Song, W, Straten, P T, Tahara, H, Tian, Z, van der Burg, S H, von Hoegen, P, Wang, E, Welters, M J, Winter, H, Withington, T, Wolchok, J D, Xiao, W, Zitvogel, L, Zwierzina, H, Marincola, F M, Gajewski, T F, Wigginton, J M & Disis, M L A 2011, ' Defining the Critical Hurdles in Cancer Immunotherapy ', Journal of Translational Medicine, vol. 9, no. 1, 214 . https://doi.org/10.1186/1479-5876-9-214
Fox, Bernard A; Schendel, Dolores J; Butterfield, Lisa H; Aamdal, Steinar; Allison, James P; Ascierto, Paolo; et al.(2011). Defining the Critical Hurdles in Cancer Immunotherapy. Journal of Translational Medicine, 9(1), 214. doi: http://dx.doi.org/10.1186/1479-5876-9-214. Retrieved from: http://www.escholarship.org/uc/item/34d0r2jw
Journal of Translational Medicine, BioMed Central, 2011, 9 (1), pp.214. 〈10.1186/1479-5876-9-214〉
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a scientific basis, others do not. We need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94757f11e84643ac70a6712fc47a36f4
http://hdl.handle.net/11568/150876
http://hdl.handle.net/11568/150876